The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Obinutuzumab (G)-atezolizumab (atezo)-lenalidomide (len) for the treatment of relapsed/refractory (R/R) follicular lymphoma (FL): Final analysis of a phase Ib/II trial.
 
Nilanjan Ghosh
Consulting or Advisory Role - Adaptive Biotechnologies; AstraZeneca; Beigene; Bristol-Myers Squibb; Genmab; Gilead Sciences; Karyopharm Therapeutics; Pharmacyclics/Janssen; Seagen; TG Therapeutics; Verastem
Speakers' Bureau - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Epizyme; Janssen Oncology; Kite/Gilead; Pharmacyclics/Janssen; Seagen
Research Funding - Forty Seven (Inst); Genentech/Roche (Inst); Juno Therapeutics (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
 
Gilles A. Salles
Honoraria - Abbvie; Celgene; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche/Genentech
Consulting or Advisory Role - Alimera Sciences; BeiGene; Bristol-Myers Squibb; Celgene; Debiopharm Group; Epizyme; Genmab; Genmab; Gilead Sciences; Incyte; Janssen; Miltenyi Biotec; morphosys; Novartis; Roche/Genentech; Velosbio
 
Izidore S. Lossos
Honoraria - Janssen Biotech
Consulting or Advisory Role - Janssen Scientific Affairs; Seagen; Verastem
Research Funding - NCI
Patents, Royalties, Other Intellectual Property - Stanford- Royalties
 
Maria Lia Palomba
Stock and Other Ownership Interests - Seres Therapeutics (I)
Honoraria - Amgen (I); Celgene; Evelo Therapeutics (I); Flagship Biosciences (I); Jazz Pharmaceuticals (I); Merck; Merck (I); Novartis (I); Pharmacyclics; Seres Therapeutics (I); Therakos (I)
Consulting or Advisory Role - Amgen (I); Celgene; Evelo Therapeutics (I); Flagship Biosciences (I); Jazz Pharmaceuticals (I); Kite, a Gilead company; Merck; Merck (I); Novartis; Novartis (I); Seres Therapeutics (I); Therakos (I)
Research Funding - Seres Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Intellectual Property Rights (I); Juno intellectual property rights (Inst)
 
Amitkumar Mehta
Stock and Other Ownership Interests - Witty Health
Consulting or Advisory Role - Aileron Therapeutics; AstraZeneca; Bristol-Myers Squibb; Carevive; Incyte; Kite, a Gilead company; Kyowa Kirin International; Pharmacyclics; Rigel; Seagen; Spectrum Pharmaceuticals; TG Therapeutics
Speakers' Bureau - AstraZeneca; Gilead Sciences; Incyte; Kite, a Gilead company; Seagen; Spectrum Pharmaceuticals
Research Funding - ADC Therapeutics; ADC Therapeutics (Inst); Affimed Therapeutics; Aileron Therapeutics (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Carevive (Inst); Epizyme (Inst); Forty Seven (Inst); Gilead Sciences (Inst); incyte (Inst); Innate Pharma; Juno Therapeutics (Inst); Merck (Inst); oncotartis (Inst); Pharmacyclics/Janssen (Inst); Rhizen Pharmaceuticals; Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics
 
Olivier Casasnovas
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; MSD; Roche; Takeda
Research Funding - Gilead Sciences (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche
 
Don A. Stevens
No Relationships to Disclose
 
Sudhakar Katakam
Employment - GCE Solutions
 
Andrea Knapp
Employment - Roche
 
Tina Nielsen
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Franck Morschhauser
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Epizyme; Gilead Sciences; Janssen; Roche; SERVIER
Speakers' Bureau - Roche
Expert Testimony - Roche